Department of Blood Transfusion, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, PR China.
Department of Anesthesiology, The First Affiliated Hospital of Xiamen University, Xiamen, PR China.
Clin Res Hepatol Gastroenterol. 2024 Oct;48(8):102451. doi: 10.1016/j.clinre.2024.102451. Epub 2024 Aug 21.
Liver cancer (LC) remains a major cause of cancer death worldwide. Grasping prevalence trends is key to informing strategies for control and prevention. We analyzed the global, regional and national trends in LC prevalence and its major causes from 1990 to 2019.
We obtained LC age-standardized prevalence rate (ASPR) estimates from the Global Burden of Disease study 2019 and assessed trends using Joinpoint regression. LC cases were categorized into those due to hepatitis B virus (HBV), hepatitis C virus (HCV), alcohol use, nonalcoholic steatohepatitis (NASH) and other causes.
While the ASPR of LC has shown a global decrease, there are specific regions where an increase in ASPR has been observed, with the highest rates in America. HBV remained the leading cause of LC (41.45 %) but significant increases occurred for HCV, alcohol use and NASH. Prevalence correlated with socioeconomic development. High-income countries had higher LC rates from HCV and alcohol but lower HBV-related LC. In high-income nations, LC prevalence climbs; the converse holds in middle- and low-income countries.
Despite a global ASPR decrease, LC due to HCV, NASH, and alcohol is rising. Prevention strategies must prioritize HBV vaccination, HCV treatment, and alcohol regulation.
The study informs targeted LC control policies and emphasizes the importance of continued monitoring and regional cooperation to combat LC.
肝癌(LC)仍然是全球癌症死亡的主要原因。掌握流行趋势对于制定控制和预防策略至关重要。我们分析了 1990 年至 2019 年全球、区域和国家 LC 流行率及其主要病因的趋势。
我们从 2019 年全球疾病负担研究中获得了 LC 年龄标准化患病率(ASPR)估计值,并使用 Joinpoint 回归评估了趋势。LC 病例分为乙型肝炎病毒(HBV)、丙型肝炎病毒(HCV)、饮酒、非酒精性脂肪性肝炎(NASH)和其他病因所致。
虽然 LC 的 ASPR 呈全球下降趋势,但某些地区的 ASPR 呈上升趋势,其中美洲的发病率最高。HBV 仍然是 LC 的主要病因(41.45%),但 HCV、饮酒和 NASH 的发病率显著上升。流行率与社会经济发展相关。高收入国家因 HCV 和酒精导致的 LC 发病率较高,但 HBV 相关的 LC 发病率较低。在高收入国家,LC 的患病率呈上升趋势;而在中低收入国家则相反。
尽管全球 ASPR 下降,但由于 HCV、NASH 和酒精导致的 LC 正在上升。预防策略必须优先考虑 HBV 疫苗接种、HCV 治疗和酒精监管。
该研究为有针对性的 LC 控制政策提供了信息,并强调了继续监测和区域合作以防治 LC 的重要性。